KENNETH JOHNSON: Open Payments
NPI 1962784785 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 21 payments from 12 companies in 2025. Trend: 2023 $416 · 2024 $443 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $98 |
| Amgen Inc. | 4 | $91 |
| Lilly USA, LLC | 2 | $54 |
| UCB, Inc. | 2 | $48 |
| PFIZER INC. | 3 | $46 |
| LEO Pharma Inc. | 1 | $31 |
| Incyte Corporation | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Organon LLC | 2 | $21 |
Products named: DUPIXENT, OTEZLA, EBGLYSS, Bimzelx, CIBINQO, ANZUPGO, OPZELURA, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
